221 related articles for article (PubMed ID: 16788930)
1. Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy.
Pandey RK; Goswami LN; Chen Y; Gryshuk A; Missert JR; Oseroff A; Dougherty TJ
Lasers Surg Med; 2006 Jun; 38(5):445-67. PubMed ID: 16788930
[TBL] [Abstract][Full Text] [Related]
2. Bacteriochlorophyll a, and its derivatives: chemistry and perspectives for cancer therapy.
Grin MC; Capital Em Cyrillicironov CA; Shtil AC
Anticancer Agents Med Chem; 2008 Aug; 8(6):683-97. PubMed ID: 18690829
[TBL] [Abstract][Full Text] [Related]
3. Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach.
Pandey SK; Gryshuk AL; Sajjad M; Zheng X; Chen Y; Abouzeid MM; Morgan J; Charamisinau I; Nabi HA; Oseroff A; Pandey RK
J Med Chem; 2005 Oct; 48(20):6286-95. PubMed ID: 16190755
[TBL] [Abstract][Full Text] [Related]
4. A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy.
Chen Y; Gryshuk A; Achilefu S; Ohulchansky T; Potter W; Zhong T; Morgan J; Chance B; Prasad PN; Henderson BW; Oseroff A; Pandey RK
Bioconjug Chem; 2005; 16(5):1264-74. PubMed ID: 16173807
[TBL] [Abstract][Full Text] [Related]
5. The role of porphyrin chemistry in tumor imaging and photodynamic therapy.
Ethirajan M; Chen Y; Joshi P; Pandey RK
Chem Soc Rev; 2011 Jan; 40(1):340-62. PubMed ID: 20694259
[TBL] [Abstract][Full Text] [Related]
6. Current clinical and preclinical photosensitizers for use in photodynamic therapy.
Detty MR; Gibson SL; Wagner SJ
J Med Chem; 2004 Jul; 47(16):3897-915. PubMed ID: 15267226
[No Abstract] [Full Text] [Related]
7. Development of bacteriochlorophyll a-based near-infrared photosensitizers conjugated to gold nanoparticles for photodynamic therapy of cancer.
Pantiushenko IV; Rudakovskaya PG; Starovoytova AV; Mikhaylovskaya AA; Abakumov MA; Kaplan MA; Tsygankov AA; Majouga AG; Grin MA; Mironov AF
Biochemistry (Mosc); 2015 Jun; 80(6):752-62. PubMed ID: 26531020
[TBL] [Abstract][Full Text] [Related]
8. Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy.
Potter WR; Henderson BW; Bellnier DA; Pandey RK; Vaughan LA; Weishaupt KR; Dougherty TJ
Photochem Photobiol; 1999 Nov; 70(5):781-8. PubMed ID: 10568170
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, optical properties and preliminary in vitro photodynamic effect of pyridyl and quinoxalyl substituted chlorins.
Li J; Zhang X; Liu Y; Yoon I; Kim DK; Yin JG; Wang JJ; Shim YK
Bioorg Med Chem; 2015 Apr; 23(8):1684-90. PubMed ID: 25797162
[TBL] [Abstract][Full Text] [Related]
10. In vitro cellular uptake and dimerization of signal transducer and activator of transcription-3 (STAT3) identify the photosensitizing and imaging-potential of isomeric photosensitizers derived from chlorophyll-a and bacteriochlorophyll-a.
Srivatsan A; Wang Y; Joshi P; Sajjad M; Chen Y; Liu C; Thankppan K; Missert JR; Tracy E; Morgan J; Rigual N; Baumann H; Pandey RK
J Med Chem; 2011 Oct; 54(19):6859-73. PubMed ID: 21842893
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy agent with a built-in apoptosis sensor for evaluating its own therapeutic outcome in situ.
Stefflova K; Chen J; Marotta D; Li H; Zheng G
J Med Chem; 2006 Jun; 49(13):3850-6. PubMed ID: 16789741
[TBL] [Abstract][Full Text] [Related]
12. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy.
O'Connor AE; Gallagher WM; Byrne AT
Photochem Photobiol; 2009; 85(5):1053-74. PubMed ID: 19682322
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and photocytotoxicity of structure-defined water-soluble C60/micelle supramolecular nanoparticles.
Metanawin T; Tang T; Chen R; Vernon D; Wang X
Nanotechnology; 2011 Jun; 22(23):235604. PubMed ID: 21483045
[TBL] [Abstract][Full Text] [Related]
14. In vivo stability and photodynamic efficacy of fluorinated bacteriopurpurinimides derived from bacteriochlorophyll-a.
Gryshuk AL; Chen Y; Potter W; Ohulchansky T; Oseroff A; Pandey RK
J Med Chem; 2006 Mar; 49(6):1874-81. PubMed ID: 16539373
[TBL] [Abstract][Full Text] [Related]
15. Getting it right: 3D cell cultures for the assessment of photosensitizers for photodynamic therapy.
Senge MO; Stafford S
Future Med Chem; 2015; 7(15):1957-60. PubMed ID: 26496381
[No Abstract] [Full Text] [Related]
16. [Fullerenes in biology].
Krokosz A
Postepy Biochem; 2007; 53(1):91-6. PubMed ID: 17718393
[TBL] [Abstract][Full Text] [Related]
17. Fullerene-pyropheophorbide a complexes as sensitizer for photodynamic therapy: uptake and photo-induced cytotoxicity on Jurkat cells.
Rancan F; Helmreich M; Mölich A; Jux N; Hirsch A; Röder B; Witt C; Böhm F
J Photochem Photobiol B; 2005 Jul; 80(1):1-7. PubMed ID: 15963432
[TBL] [Abstract][Full Text] [Related]
18. A study on the photodynamic properties of chlorophyll derivatives using human hepatocellular carcinoma cells.
Li WT; Tsao HW; Chen YY; Cheng SW; Hsu YC
Photochem Photobiol Sci; 2007 Dec; 6(12):1341-8. PubMed ID: 18046491
[TBL] [Abstract][Full Text] [Related]
19. Bilirubin ditaurate--a sensitive compound for examination of photosensitizers.
Jirsa M; Jirsa M; Kubát P
Sb Lek; 1995; 96(1):1-6. PubMed ID: 8711360
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro testing of a pyropheophorbide-a-fullerene hexakis adduct immunoconjugate for photodynamic therapy.
Rancan F; Helmreich M; Mölich A; Ermilov EA; Jux N; Röder B; Hirsch A; Böhm F
Bioconjug Chem; 2007; 18(4):1078-86. PubMed ID: 17550226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
